Matthew L. Posard
CIK 1543792 · Chief Commercial Officer · last filed 2026-05-07
Matthew L. Posard is a Chief Commercial Officer who has filed 39 SEC Form 4 insider transactions across 6 companies since 2012. The most recent filing, for HTI, was dated May 7, 2026. Across all open-market trades the lifetime net is −$5.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.26M
6
39
-$5.17M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTI | Director | 77,835 | — | — | -$4.40M | 16 | 2026-05-07 |
| NAUT | Director | 130,000 | $2.24 | $291.2K | $225.5K | 5 | 2025-06-25 |
| Talis Biomedical Corp (TLIS) Delisted | Director | 62,500 | $2.84 | $177.5K | $1.00M | 3 | 2023-06-12 |
| DermTech, Inc. (DMTK) Delisted | Director | 158,215 | $0.09 | $14.9K | $1000.0K | 8 | 2023-06-05 |
| Cardiff Oncology, Inc. (TROVW) Delisted | Chief Commercial Officer | — | — | — | $0 | 1 | 2016-01-06 |
| ILMN | Sr VP & General Manager | 30,858 | $160.97 | $4.97M | -$3.00M | 6 | 2013-05-30 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-07 | HTI | Grant (A) | +3,796 | $0 | EDGAR |
| 2025-06-25 | NAUT | Grant (A) | — | $0 | EDGAR |
| 2025-05-02 | HTI | Grant (A) | +4,165 | $0 | EDGAR |
| 2024-08-14 | HTI | Sell (S) | −29,881 | -$1.69M | EDGAR |
| 2024-06-17 | NAUT | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | HTI | Sell (S) | −20,000 | -$1.01M | EDGAR |
| 2024-04-29 | HTI | Grant (A) | +6,501 | $0 | EDGAR |
| 2023-06-16 | NAUT | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | Talis Biomedical Corp (TLIS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | DermTech, Inc. (DMTK) Delisted | Grant (A) | +35,714 | $0 | EDGAR |